Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-08-21

Neogen (NEOG)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$6,824,891
John Adent total, FY2025
26th
CEO pay percentile vs peers
152:1
CEO-to-median pay ratio
90.43%
Say-on-pay support, latest vote
Companies that benchmark against NEOG
5 companies name NEOG as a compensation peer

Each company listed discloses NEOG in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named NEOG in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
John Adent$810,000$0$1,800,000$4,200,000$0$0$14,891$6,824,891
President & Chief Executive Officer
David Naemura571,5000836,4001,254,6000017,6812,680,181
Chief Financial Officer & Chief Operating Officer
Douglas Jones464,3220720,0001,080,0000012,1392,276,461
Chief Operating Officer (Retired)
Amy Rocklin447,6940520,000780,0000020,0731,767,767
Chief Legal & Compliance Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
John Adent$6,824,891
David Naemura2,680,181
Douglas Jones2,276,461
Amy Rocklin1,767,767

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
James C. BorelDirector2025-10-07A2,071$6$11,660CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-07A2,071611,660CommonForm 4 ↗
Douglas JonesFormer COO2025-10-07A12,940672,852CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-07A32,9366185,430CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-07D32,9366185,430Derivative, Class A CommonForm 4 ↗
James P. TobinDirector2025-10-07A2,071611,660CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-07D3,534619,896CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-07D9,297652,342CommonForm 4 ↗
Douglas JonesFormer COO2025-10-07D6,329635,632CommonForm 4 ↗
William T. BoehmDirector2025-10-07A2,071611,660CommonForm 4 ↗
William T. BoehmDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
James C. BorelDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-07A9,036548,433CommonForm 4 ↗
Ronald D. GreenDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-07A2,071611,660CommonForm 4 ↗
Douglas JonesFormer COO2025-10-07D12,940672,852Derivative, Class A CommonForm 4 ↗
Aashima GuptaDirector2025-10-07A2,071611,660CommonForm 4 ↗
Aashima GuptaDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-07D9,036650,873Derivative, Class A CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
James P. TobinDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-07A2,071611,660CommonForm 4 ↗
Ronald D. GreenDirector2025-10-07A2,071611,660CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-13A29461,776CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-13D86565,225CommonForm 4 ↗
Dividend-equivalent accruals2025-10-131,077~6,5052 insiders, 2 accrual rows
Douglas JonesFormer COO2025-10-13D38362,313CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-13D1156695CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-13A3,063618,501CommonForm 4 ↗
Douglas JonesFormer COO2025-10-13A78364,729CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-13D3,063618,501Derivative, Class A CommonForm 4 ↗
Aashima GuptaDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Andrea F. WainerDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Ronald D. GreenDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Ronald D. GreenDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Thierry L. BernardDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
James C. BorelDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Thierry L. BernardDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Aashima GuptaDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-23A19,7696119,998CommonForm 4 ↗
James C. BorelDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Andrea F. WainerDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Avi PelossofDirector2025-10-24A19,3866119,999CommonForm 4 ↗
Avi PelossofDirector2025-10-24A49,92900Derivative, Class A CommonForm 4 ↗
Ronald D. GreenDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
James C. BorelDirector2025-10-27A2,025612,535CommonForm 4 ↗
David NaemuraChief Financial Officer2025-10-27A15,504695,970CommonForm 4 ↗
Aashima GuptaDirector2025-10-27A1,777611,000CommonForm 4 ↗
David NaemuraChief Financial Officer2025-10-27D15,504695,970Derivative, Class A CommonForm 4 ↗
William T. BoehmDirector2025-10-27D3,553621,567Derivative, Class A CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-27D38,7596239,918Derivative, Class A CommonForm 4 ↗
James C. BorelDirector2025-10-27A1,777611,000CommonForm 4 ↗
James C. BorelDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-27A1,777611,000CommonForm 4 ↗
Aashima GuptaDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
James P. TobinDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-27A9,474658,644CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-27D2,085612,906CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-27D9,474658,644Derivative, Class A CommonForm 4 ↗
Douglas JonesFormer COO2025-10-27D3,481621,547CommonForm 4 ↗
Douglas JonesFormer COO2025-10-27D15,504695,970Derivative, Class A CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-27A38,7596239,918CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-27D8,527652,782CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-27A2,025612,535CommonForm 4 ↗
James C. BorelDirector2025-10-27D2,025612,535Derivative, Class A CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-27A1,777611,000CommonForm 4 ↗
James P. TobinDirector2025-10-27A1,777611,000CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-27A1,777611,000CommonForm 4 ↗
William T. BoehmDirector2025-10-27A3,553621,567CommonForm 4 ↗
Douglas JonesFormer COO2025-10-27A15,504695,970CommonForm 4 ↗
David NaemuraChief Financial Officer2025-10-27D4,261626,376CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Ronald D. GreenDirector2025-10-27A1,777611,000CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-27D2,025612,535Derivative, Class A CommonForm 4 ↗
Mikhael NassifDirector2025-11-03A17761,106Common, indirectForm 4 ↗
Richard Bryan RiggsbeeCFO2025-11-03A178,85561,124,998CommonForm 4 ↗
Richard Bryan RiggsbeeCFO2025-11-03A459,71300Derivative, Class A CommonForm 4 ↗
David NaemuraFormer CFO2025-12-01A12,912677,214CommonForm 4 ↗
David NaemuraFormer CFO2025-12-01D3,548621,217CommonForm 4 ↗
David NaemuraFormer CFO2025-12-01D12,912677,214Derivative, Class A CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A50,8137375,000CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A50,8137375,000CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A50,8137375,000CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A130,60500Derivative, Class A CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A261,21000Derivative, Class A CommonForm 4 ↗
Mikhael NassifDirector2026-01-16A13791,279Common, indirectForm 4 ↗
Mikhael NassifDirector2026-01-26A2410240Common, indirectForm 4 ↗
Mikhael NassifDirector2026-01-26A2510246Common, indirectForm 4 ↗
Mikhael NassifDirector2026-02-17A2311252Common, indirectForm 4 ↗
Jennifer Evans StaceyChief Legal Officer2026-05-01A89,52000Derivative, Class A CommonForm 4 ↗
Jennifer Evans StaceyChief Legal Officer2026-05-01A39,34910374,996CommonForm 4 ↗
John Patrick MoylanChief Accounting Officer2026-05-04A4,5581043,438CommonForm 4 ↗
John Patrick MoylanChief Accounting Officer2026-05-04D4,5581043,438Derivative, Class A CommonForm 4 ↗
John Patrick MoylanChief Accounting Officer2026-05-04D1,5681014,943CommonForm 4 ↗
Amy RocklinFormer Chief Legal Officer2026-05-18D35,1839326,850Derivative, Class A CommonForm 4 ↗
Amy RocklinFormer Chief Legal Officer2026-05-18D10,241995,139CommonForm 4 ↗
Amy RocklinFormer Chief Legal Officer2026-05-18A35,1839326,850CommonForm 4 ↗
John Patrick MoylanChief Accounting Officer2026-06-03D2,553922,339CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 108 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
James C. BorelDirector2025-10-07A2,071$6$11,660CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-07A2,071611,660CommonForm 4 ↗
Douglas JonesFormer COO2025-10-07A12,940672,852CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-07A32,9366185,430CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-07D32,9366185,430Derivative, Class A CommonForm 4 ↗
James P. TobinDirector2025-10-07A2,071611,660CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-07D3,534619,896CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-07D9,297652,342CommonForm 4 ↗
Douglas JonesFormer COO2025-10-07D6,329635,632CommonForm 4 ↗
William T. BoehmDirector2025-10-07A2,071611,660CommonForm 4 ↗
William T. BoehmDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
James C. BorelDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-07A9,036548,433CommonForm 4 ↗
Ronald D. GreenDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-07A2,071611,660CommonForm 4 ↗
Douglas JonesFormer COO2025-10-07D12,940672,852Derivative, Class A CommonForm 4 ↗
Aashima GuptaDirector2025-10-07A2,071611,660CommonForm 4 ↗
Aashima GuptaDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-07D9,036650,873Derivative, Class A CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
James P. TobinDirector2025-10-07D2,071611,660Derivative, Class A CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-07A2,071611,660CommonForm 4 ↗
Ronald D. GreenDirector2025-10-07A2,071611,660CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-13A29461,776CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-13D86565,225CommonForm 4 ↗
Douglas JonesFormer COO2025-10-13D78364,729Derivative, Class A CommonForm 4 ↗
Douglas JonesFormer COO2025-10-13D38362,313CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-13D1156695CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-13A3,063618,501CommonForm 4 ↗
Douglas JonesFormer COO2025-10-13A78364,729CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-13D3,063618,501Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-13D29461,776Derivative, Class A CommonForm 4 ↗
Aashima GuptaDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Andrea F. WainerDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Ronald D. GreenDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Ronald D. GreenDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Thierry L. BernardDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
James C. BorelDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Thierry L. BernardDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Aashima GuptaDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-23A19,7696119,998CommonForm 4 ↗
James C. BorelDirector2025-10-23A19,7696119,998CommonForm 4 ↗
Andrea F. WainerDirector2025-10-23A50,81400Derivative, Class A CommonForm 4 ↗
Avi PelossofDirector2025-10-24A19,3866119,999CommonForm 4 ↗
Avi PelossofDirector2025-10-24A49,92900Derivative, Class A CommonForm 4 ↗
Ronald D. GreenDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
James C. BorelDirector2025-10-27A2,025612,535CommonForm 4 ↗
David NaemuraChief Financial Officer2025-10-27A15,504695,970CommonForm 4 ↗
Aashima GuptaDirector2025-10-27A1,777611,000CommonForm 4 ↗
David NaemuraChief Financial Officer2025-10-27D15,504695,970Derivative, Class A CommonForm 4 ↗
William T. BoehmDirector2025-10-27D3,553621,567Derivative, Class A CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-27D38,7596239,918Derivative, Class A CommonForm 4 ↗
James C. BorelDirector2025-10-27A1,777611,000CommonForm 4 ↗
James C. BorelDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-27A1,777611,000CommonForm 4 ↗
Aashima GuptaDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
James P. TobinDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-27A9,474658,644CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-27D2,085612,906CommonForm 4 ↗
Amy RocklinChief Legal Officer2025-10-27D9,474658,644Derivative, Class A CommonForm 4 ↗
Douglas JonesFormer COO2025-10-27D3,481621,547CommonForm 4 ↗
Douglas JonesFormer COO2025-10-27D15,504695,970Derivative, Class A CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-27A38,7596239,918CommonForm 4 ↗
John Edward AdentFormer CEO2025-10-27D8,527652,782CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-27A2,025612,535CommonForm 4 ↗
James C. BorelDirector2025-10-27D2,025612,535Derivative, Class A CommonForm 4 ↗
Raphael A. RodriguezDirector2025-10-27A1,777611,000CommonForm 4 ↗
James P. TobinDirector2025-10-27A1,777611,000CommonForm 4 ↗
Catherine E. WotekiDirector2025-10-27A1,777611,000CommonForm 4 ↗
William T. BoehmDirector2025-10-27A3,553621,567CommonForm 4 ↗
Douglas JonesFormer COO2025-10-27A15,504695,970CommonForm 4 ↗
David NaemuraChief Financial Officer2025-10-27D4,261626,376CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-27D1,777611,000Derivative, Class A CommonForm 4 ↗
Ronald D. GreenDirector2025-10-27A1,777611,000CommonForm 4 ↗
Jeffrey D. CapelloDirector2025-10-27D2,025612,535Derivative, Class A CommonForm 4 ↗
Mikhael NassifDirector2025-11-03A17761,106Common, indirectForm 4 ↗
Richard Bryan RiggsbeeCFO2025-11-03A178,85561,124,998CommonForm 4 ↗
Richard Bryan RiggsbeeCFO2025-11-03A459,71300Derivative, Class A CommonForm 4 ↗
David NaemuraFormer CFO2025-12-01A12,912677,214CommonForm 4 ↗
David NaemuraFormer CFO2025-12-01D3,548621,217CommonForm 4 ↗
David NaemuraFormer CFO2025-12-01D12,912677,214Derivative, Class A CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A50,8137375,000CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A50,8137375,000CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A50,8137375,000CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A130,60500Derivative, Class A CommonForm 4 ↗
Tamara A. RanalliSenior Vice President2026-01-07A261,21000Derivative, Class A CommonForm 4 ↗
Mikhael NassifDirector2026-01-16A13791,279Common, indirectForm 4 ↗
Mikhael NassifDirector2026-01-26A2410240Common, indirectForm 4 ↗
Mikhael NassifDirector2026-01-26A2510246Common, indirectForm 4 ↗
Mikhael NassifDirector2026-02-17A2311252Common, indirectForm 4 ↗
Jennifer Evans StaceyChief Legal Officer2026-05-01A89,52000Derivative, Class A CommonForm 4 ↗
Jennifer Evans StaceyChief Legal Officer2026-05-01A39,34910374,996CommonForm 4 ↗
John Patrick MoylanChief Accounting Officer2026-05-04A4,5581043,438CommonForm 4 ↗
John Patrick MoylanChief Accounting Officer2026-05-04D4,5581043,438Derivative, Class A CommonForm 4 ↗
John Patrick MoylanChief Accounting Officer2026-05-04D1,5681014,943CommonForm 4 ↗
Amy RocklinFormer Chief Legal Officer2026-05-18D35,1839326,850Derivative, Class A CommonForm 4 ↗
Amy RocklinFormer Chief Legal Officer2026-05-18D10,241995,139CommonForm 4 ↗
Amy RocklinFormer Chief Legal Officer2026-05-18A35,1839326,850CommonForm 4 ↗
John Patrick MoylanChief Accounting Officer2026-06-03D2,553922,339CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
David NaemuraOPTION2025-01-1645,150$291,000
Douglas JonesOptions/SARs2024-08-15201,7641,800,000
David NaemuraOptions/SARs2024-08-15201,7641,800,000
Amy RocklinOptions/SARs2024-08-15145,7181,300,000
John AdentOptions/SARs2024-08-15784,6366,000,000
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
David Naemura$0$0$291,0000.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
John AdentOption30,75034.15
Douglas JonesOption8,83528.4
Douglas JonesOption201,76416.79
David NaemuraOption374,13015.48
Amy RocklinOption5,89028.4
Amy RocklinOption40,17913.28
Amy RocklinOption145,71816.79
David NaemuraRSU300,1091,758,632
Douglas JonesRSU213,8151,252,954
Douglas JonesRSU42,883251,294
David NaemuraRSU42,883251,294
Douglas JonesRSU31,008181,707
David NaemuraRSU31,008181,707
Amy RocklinRSU30,971181,490
Amy RocklinRSU18,949111,041
David NaemuraRSU12,91275,664
Douglas JonesRSU12,37872,535
David NaemuraRSU10,03458,799
Amy RocklinRSU9,03652,951
John AdentRSU2,81616,502
David NaemuraOption45,15011.6
Douglas JonesRSU1,6909,903
Douglas JonesRSU1,5679,183
Amy RocklinRSU1,1276,604
Amy RocklinRSU5883,446
Douglas JonesRSU5623,293
Douglas JonesOption3,95434.15
Douglas JonesOption9,88740.85
David NaemuraOption57,47115.49
David NaemuraOption201,76416.79
Amy RocklinOption73,15015.48
John AdentRSU914,1615,356,977
John AdentRSU107,207628,233
John AdentRSU77,519454,261
Amy RocklinRSU131,328769,582
John AdentRSU30,120176,503
John AdentRSU6,12735,904
John AdentRSU4,22624,764
John AdentOption465,50115.48
John AdentOption60,14340.85
John AdentOption34,35728.4
John AdentOption208,33613.28
John AdentOption784,63616.79
Douglas JonesOption55,03513.28
Douglas JonesOption119,70015.48
Amy RocklinOption3,70840.85
05

Incentive-plan design — the Compensation Discussion & Analysis

An important element of our overall compensation philosophy is to deliver a total compensation opportunity that is competitive with the market median with the ability to differentiate based on individual performance, future potential, strategic needs, labor market for talent and other individual and company-specific attributes.

CEO STI target (% of salary)100%
CEO LTI target (% of salary)
Independent consultantFarient Advisors, LLC
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20252025-10-23167,126,87317,679,601412,66790.43%Passed
20242024-10-2496,518,858101,431,438677,52548.76%Failed
20232023-10-25188,942,1946,399,654294,34296.72%Passed
20222022-10-0674,522,7883,427,649311,06095.6%Passed
20212021-10-0791,114,0773,300,741204,85396.5%Passed
20202020-10-0845,126,250869,819109,28298.11%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20252025-10-2390.43%a
20242024-10-2448.76%b
20232023-10-2596.72%c

a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will not be counted as votes cast so will not have any effect on the outcome of this proposal.”.

b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will not be counted as votes cast so will not have any effect on the outcome of this proposal.”.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)152 : 1
CEO total compensation$8,863,146
Median employee compensation$58,231
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
James C. BorelIndependent · Board Chair · Audit · Governance (Chair)$127,500$82,500$82,500$0$0$292,500
William T. Boehm, Ph.DIndependent · Audit (Chair) · Compensation · Not standing for re-election · Departed during FY82,50082,50082,50000247,500
James P. TobinIndependent · Departed during FY80,00082,50082,50000245,000
Catherine E. Woteki, Ph.DIndependent · Compensation (Chair) · Science, Technology and Innovation77,50082,50082,50000242,500
Ronald D. Green, Ph.DIndependent · Governance · Science, Technology and Innovation (Chair)77,50082,50082,50000242,500
Jeffrey D. CapelloIndependent · Audit · Compensation72,50082,50082,50000237,500
Raphael A. RodriguezIndependent · Compensation · Science, Technology and Innovation70,00082,50082,50000235,000
Aashima GuptaIndependent · Governance · Science, Technology and Innovation70,00082,50082,50000235,000
Thierry L. BernardIndependent · Compensation · Governance64,16781,15081,15000226,467
John E. AdentEmployee director · Not standing for re-election · Departed during FY00000
Andrea F. WainerIndependent · Audit · Science, Technology and Innovation · Newly elected000000
Avi PelossofIndependent · Newly elected000000
Mikhael NassifEmployee director · Newly elected00000
09

Board fee structure and ownership guideline

Annual cash retainer$55,000
Annual equity retainer$240,000
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)10,000 / 7,500 / 7,500
Stock ownership guideline5x annual cash retainer
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$721,667
Equity awards (grant-date value)$741,150
All other compensation$0
Total cost of the board$1,462,817

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Neogen names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Neogen.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Exact Sciences Corporation2024Kevin Conroy$1,083,368$13,496,138$0$712,329$15,539,378
2Charles River Laboratories, Inc.2025James Foster1,545,63611,601,08902,182,66615,435,220
3Natera, Inc.2025Steven Chapman853,71012,979,55801,114,15114,957,319
4IDEXX Laboratories, Inc.2025Jonathan Mazelsky1,150,0005,399,8815,400,0012,593,00014,580,122
5Waters Corporation2025Udit Batra1,150,0007,430,2472,999,9222,371,87513,973,044
6QuidelOrtho Corporation2025Brian Blaser1,000,0008,965,82201,274,50011,255,782
7Sotera Health Company2025Michael Petras1,130,6998,022,40001,484,89010,656,063
8Azenta, Inc.2025John Marotta900,0008,386,29701,063,65610,371,414
9Maravai LifeScience Holdings, Inc.2025Bernd Brust388,8637,660,0001,460,000425,34310,129,708
10NeoGenomics, Inc.2025Tony Zook601,5393,999,9973,998,235513,4009,127,092
11Guardant Health, Inc.2025AmirAli Talasaz18,647,709008,661,227
12Bio-Techne Corporation2025Kim Kelderman936,0003,929,9421,932,8481,318,9178,151,181
13Bio-Rad Laboratories, Inc.2025Norman Schwartz1,089,8774,856,5741,458,975562,0887,995,841
14Neogen2025John Adent810,0001,800,0004,200,00006,824,891
15Mettler-Toledo International, Inc.2025Patrick Kaltenbach1,145,9993,267,8081,635,033462,9846,741,212
16Repligen Corporation2025Olivier Loeillot860,0003,374,8531,095,626774,0006,114,771
17Bruker Corporation2025Frank Laukien976,5541,623,4071,488,109587,2704,706,388
18OraSure Technologies, Inc.2025Carrie Eglinton Manner721,0003,394,1880173,0404,292,228

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Neogennot disclosedPSU 50 · Option 50not disclosedFarient Advisors, LLC
Azenta, Inc.107.4%PSU 50 · RSU 50Yes — Relative Total Shareholder Return (rTSR)Pearl Meyer
Bio-Rad Laboratories, Inc.not disclosednot disclosednot disclosedCompensia, Inc.
Bio-Techne Corporation128.1%PSU 50 · Options 25 · RSU 25NoAon Talent
Bruker Corporation43.0%RSU 52 · Options 48not disclosedAon's Human Capital Solutions Practice
Charles River Laboratories, Inc.139%PSU 60 · RSU 40Yes — Three-year rTSRPay Governance
Exact Sciences Corporation47%PSU 60 · RSU 40NoAon
Guardant Health, Inc.140%PSU 50 · RSU 50NoAon
IDEXX Laboratories, Inc.140%Options 50 · PSU 50NoFarient
Maravai LifeScience Holdings, Inc.not disclosednot disclosedNoMeridian Compensation Partners, LLC
Mettler-Toledo International, Inc.80%PSU 33 · RSU 33 · Options 33Yes — Relative Total Shareholder Return (rTSR)Pearl Meyer & Partners (PM&P)
Natera, Inc.131.1%PSU 50 · RSU 50NoAon
NeoGenomics, Inc.60%RSU 50 · Options 50not disclosedWTW
OraSure Technologies, Inc.24.0%RSU 50 · PSU 50Yes — Relative TSR performance vs peer groupPay Governance LLC
QuidelOrtho Corporation127%PSU 60 · RSU 40Yes — Total Shareholder Return (TSR)Compensia
Repligen Corporation100%RSU 50 · PSU 25 · Options 25NoMeridian Compensation Partners, LLC
Sotera Health Company103%PSU 40 · RSU 40 · Other 20NoExequity
Waters Corporation110%PSU 50 · Options 35 · RSU 15Yes — Relative Total Shareholder Return (rTSR)Pearl Meyer

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, John AdentDEF 14A2025-09-120000950170-25-114381Section “Summary Compensation Table”. As printed: 6,824,891. Filing ↗machine: r3 · c31 · span 1277142–1277151
2Section 01, David NaemuraDEF 14A2025-09-120000950170-25-114381Section “Summary Compensation Table”. As printed: 2,680,181. Filing ↗machine: r9 · c31 · span 1353342–1353351
3Section 01, Douglas JonesDEF 14A2025-09-120000950170-25-114381Section “Summary Compensation Table”. As printed: 2,276,461. Filing ↗machine: r6 · c31 · span 1315254–1315263
4Section 01, Amy RocklinDEF 14A2025-09-120000950170-25-114381Section “Summary Compensation Table”. As printed: 1,767,767. Filing ↗machine: r12 · c31 · span 1391244–1391253
5Section 03, David Naemura OPTIONDEF 14A2025-09-120000950170-25-114381Section “ESPP” · grants of plan-based awards table. Filing ↗machine: t94 · r7 · c33 · span 1504963–1504970
6Section 03, Douglas Jones Options/SARsDEF 14A2025-09-120000950170-25-114381Section “LTI V” · grants of plan-based awards table. Filing ↗machine: t81 · r4 · c3 · span 1069342–1069349
7Section 03, David Naemura Options/SARsDEF 14A0000950170-25-114381Section “LTI V” · grants of plan-based awards table. Filing ↗machine: t80 · r5 · c6 · span 1050913–1050922
8Section 03, Amy Rocklin Options/SARsDEF 14A2025-09-120000950170-25-114381Section “LTI V” · grants of plan-based awards table. Filing ↗machine: t80 · r6 · c3 · span 1053263–1053272
9Section 03, John Adent Options/SARsDEF 14A2025-09-120000950170-25-114381Section “LTI V” · grants of plan-based awards table. Filing ↗machine: t81 · r3 · c3 · span 1065274–1065281
10Section 07, pay ratioDEF 14A2026-08-210001193125-26-360742Section “CEO Pay Ratio”. As printed: 152 : 1. Filing ↗
11Section 08, James C. BorelDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 292,500. Filing ↗machine: t117 · r5 · c18 · span 2437292–2437299
12Section 08, William T. Boehm, Ph.DDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 247,500. Filing ↗machine: t117 · r4 · c18 · span 2429712–2429719
13Section 08, James P. TobinDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 245,000. Filing ↗machine: t117 · r10 · c18 · span 2475204–2475211
14Section 08, Catherine E. Woteki, Ph.DDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 242,500. Filing ↗machine: t117 · r11 · c18 · span 2483460–2483467
15Section 08, Ronald D. Green, Ph.DDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 242,500. Filing ↗machine: t117 · r7 · c18 · span 2452462–2452469
16Section 08, Jeffrey D. CapelloDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 237,500. Filing ↗machine: t117 · r6 · c18 · span 2444875–2444882
17Section 08, Raphael A. RodriguezDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 235,000. Filing ↗machine: t117 · r9 · c18 · span 2467625–2467632
18Section 08, Aashima GuptaDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 235,000. Filing ↗machine: t117 · r8 · c18 · span 2460040–2460047
19Section 08, Thierry L. BernardDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 226,467. Filing ↗machine: t117 · r3 · c18 · span 2422124–2422131
20Section 08, John E. AdentDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 0. Filing ↗
21Section 08, Andrea F. WainerDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 0. Filing ↗
22Section 08, Avi PelossofDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 0. Filing ↗
23Section 08, Mikhael NassifDEF 14A2025-09-120000950170-25-114381Section “Director Compensation”. As printed: 0. Filing ↗
24Section 02, James C. Borel 2025-10-07Form 42025-10-090000711377-25-000036Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Catherine E. Woteki 2025-10-07Form 42025-10-090000711377-25-000042Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Douglas Jones 2025-10-07Form 42025-10-090000711377-25-000044Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, John Edward Adent 2025-10-07Form 42025-10-090000711377-25-000043Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, John Edward Adent 2025-10-07Form 42025-10-090000711377-25-000043Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, James P. Tobin 2025-10-07Form 42025-10-090000711377-25-000041Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Jeffrey D. Capello 2025-10-07Form 42025-10-090000711377-25-000037Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Amy Rocklin 2025-10-07Form 42025-10-090000711377-25-000045Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, John Edward Adent 2025-10-07Form 42025-10-090000711377-25-000043Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Douglas Jones 2025-10-07Form 42025-10-090000711377-25-000044Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, William T. Boehm 2025-10-07Form 42025-10-090000711377-25-000035Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, William T. Boehm 2025-10-07Form 42025-10-090000711377-25-000035Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, James C. Borel 2025-10-07Form 42025-10-090000711377-25-000036Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Amy Rocklin 2025-10-07Form 42025-10-090000711377-25-000045Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Ronald D. Green 2025-10-07Form 42025-10-090000711377-25-000038Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Raphael A. Rodriguez 2025-10-07Form 42025-10-090000711377-25-000040Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Jeffrey D. Capello 2025-10-07Form 42025-10-090000711377-25-000037Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Douglas Jones 2025-10-07Form 42025-10-090000711377-25-000044Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Aashima Gupta 2025-10-07Form 42025-10-090000711377-25-000039Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Aashima Gupta 2025-10-07Form 42025-10-090000711377-25-000039Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Amy Rocklin 2025-10-07Form 42025-10-090000711377-25-000045Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Catherine E. Woteki 2025-10-07Form 42025-10-090000711377-25-000042Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, James P. Tobin 2025-10-07Form 42025-10-090000711377-25-000041Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Raphael A. Rodriguez 2025-10-07Form 42025-10-090000711377-25-000040Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Ronald D. Green 2025-10-07Form 42025-10-090000711377-25-000038Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Amy Rocklin 2025-10-13Form 42025-10-140000711377-25-000048Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, John Edward Adent 2025-10-13Form 42025-10-140000711377-25-000046Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Douglas Jones 2025-10-13Form 42025-10-140000711377-25-000047Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Douglas Jones 2025-10-13Form 42025-10-140000711377-25-000047Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Amy Rocklin 2025-10-13Form 42025-10-140000711377-25-000048Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, John Edward Adent 2025-10-13Form 42025-10-140000711377-25-000046Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Douglas Jones 2025-10-13Form 42025-10-140000711377-25-000047Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, John Edward Adent 2025-10-13Form 42025-10-140000711377-25-000046Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Amy Rocklin 2025-10-13Form 42025-10-140000711377-25-000048Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Aashima Gupta 2025-10-23Form 42025-10-270000711377-25-000053Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Catherine E. Woteki 2025-10-23Form 42025-10-270000711377-25-000056Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Andrea F. Wainer 2025-10-23Form 42025-10-270000711377-25-000055Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Raphael A. Rodriguez 2025-10-23Form 42025-10-270000711377-25-000054Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Raphael A. Rodriguez 2025-10-23Form 42025-10-270000711377-25-000054Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Ronald D. Green 2025-10-23Form 42025-10-270000711377-25-000052Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Ronald D. Green 2025-10-23Form 42025-10-270000711377-25-000052Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Jeffrey D. Capello 2025-10-23Form 42025-10-270000711377-25-000051Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Thierry L. Bernard 2025-10-23Form 42025-10-270000711377-25-000050Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, James C. Borel 2025-10-23Form 42025-10-270000711377-25-000049Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Thierry L. Bernard 2025-10-23Form 42025-10-270000711377-25-000050Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Catherine E. Woteki 2025-10-23Form 42025-10-270000711377-25-000056Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Aashima Gupta 2025-10-23Form 42025-10-270000711377-25-000053Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Jeffrey D. Capello 2025-10-23Form 42025-10-270000711377-25-000051Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, James C. Borel 2025-10-23Form 42025-10-270000711377-25-000049Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Andrea F. Wainer 2025-10-23Form 42025-10-270000711377-25-000055Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Avi Pelossof 2025-10-24Form 42025-10-280000711377-25-000058Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Avi Pelossof 2025-10-24Form 42025-10-280000711377-25-000058Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Ronald D. Green 2025-10-27Form 42025-10-290000711377-25-000070Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, James C. Borel 2025-10-27Form 42025-10-280000711377-25-000059Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, David Naemura 2025-10-27Form 42025-10-280000711377-25-000064Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Aashima Gupta 2025-10-27Form 42025-10-290000711377-25-000069Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, David Naemura 2025-10-27Form 42025-10-280000711377-25-000064Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, William T. Boehm 2025-10-27Form 42025-10-280000711377-25-000061Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, John Edward Adent 2025-10-27Form 42025-10-280000711377-25-000062Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, James C. Borel 2025-10-27Form 42025-10-290000711377-25-000072Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, James C. Borel 2025-10-27Form 42025-10-290000711377-25-000072Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Jeffrey D. Capello 2025-10-27Form 42025-10-290000711377-25-000071Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Aashima Gupta 2025-10-27Form 42025-10-290000711377-25-000069Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Raphael A. Rodriguez 2025-10-27Form 42025-10-280000711377-25-000068Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, James P. Tobin 2025-10-27Form 42025-10-280000711377-25-000067Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Catherine E. Woteki 2025-10-27Form 42025-10-280000711377-25-000066Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Amy Rocklin 2025-10-27Form 42025-10-280000711377-25-000065Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Amy Rocklin 2025-10-27Form 42025-10-280000711377-25-000065Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Amy Rocklin 2025-10-27Form 42025-10-280000711377-25-000065Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Douglas Jones 2025-10-27Form 42025-10-280000711377-25-000063Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Douglas Jones 2025-10-27Form 42025-10-280000711377-25-000063Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, John Edward Adent 2025-10-27Form 42025-10-280000711377-25-000062Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, John Edward Adent 2025-10-27Form 42025-10-280000711377-25-000062Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Jeffrey D. Capello 2025-10-27Form 42025-10-280000711377-25-000060Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, James C. Borel 2025-10-27Form 42025-10-280000711377-25-000059Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Raphael A. Rodriguez 2025-10-27Form 42025-10-280000711377-25-000068Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, James P. Tobin 2025-10-27Form 42025-10-280000711377-25-000067Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, Catherine E. Woteki 2025-10-27Form 42025-10-280000711377-25-000066Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, William T. Boehm 2025-10-27Form 42025-10-280000711377-25-000061Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, Douglas Jones 2025-10-27Form 42025-10-280000711377-25-000063Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, David Naemura 2025-10-27Form 42025-10-280000711377-25-000064Insider equity transaction reported since the proxy statement. Filing ↗
105Section 02, Jeffrey D. Capello 2025-10-27Form 42025-10-290000711377-25-000071Insider equity transaction reported since the proxy statement. Filing ↗
106Section 02, Ronald D. Green 2025-10-27Form 42025-10-290000711377-25-000070Insider equity transaction reported since the proxy statement. Filing ↗
107Section 02, Jeffrey D. Capello 2025-10-27Form 42025-10-280000711377-25-000060Insider equity transaction reported since the proxy statement. Filing ↗
108Section 02, Mikhael Nassif 2025-11-03Form 42025-11-070000711377-25-000076Insider equity transaction reported since the proxy statement. Filing ↗
109Section 02, Richard Bryan Riggsbee 2025-11-03Form 42025-11-050000711377-25-000074Insider equity transaction reported since the proxy statement. Filing ↗
110Section 02, Richard Bryan Riggsbee 2025-11-03Form 42025-11-050000711377-25-000074Insider equity transaction reported since the proxy statement. Filing ↗
111Section 02, David Naemura 2025-12-01Form 42025-12-020000711377-25-000077Insider equity transaction reported since the proxy statement. Filing ↗
112Section 02, David Naemura 2025-12-01Form 42025-12-020000711377-25-000077Insider equity transaction reported since the proxy statement. Filing ↗
113Section 02, David Naemura 2025-12-01Form 42025-12-020000711377-25-000077Insider equity transaction reported since the proxy statement. Filing ↗
114Section 02, Tamara A. Ranalli 2026-01-07Form 42026-01-290000711377-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
115Section 02, Tamara A. Ranalli 2026-01-07Form 42026-01-260000711377-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
116Section 02, Tamara A. Ranalli 2026-01-07Form 42026-01-290000711377-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
117Section 02, Tamara A. Ranalli 2026-01-07Form 42026-01-260000711377-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
118Section 02, Tamara A. Ranalli 2026-01-07Form 42026-01-290000711377-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
119Section 02, Mikhael Nassif 2026-01-16Form 42026-01-160000711377-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
120Section 02, Mikhael Nassif 2026-01-26Form 42026-02-020000711377-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
121Section 02, Mikhael Nassif 2026-01-26Form 42026-02-020000711377-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
122Section 02, Mikhael Nassif 2026-02-17Form 42026-02-170000711377-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
123Section 02, Jennifer Evans Stacey 2026-05-01Form 42026-05-040000711377-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
124Section 02, Jennifer Evans Stacey 2026-05-01Form 42026-05-040000711377-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
125Section 02, John Patrick Moylan 2026-05-04Form 42026-05-050000711377-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
126Section 02, John Patrick Moylan 2026-05-04Form 42026-05-050000711377-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
127Section 02, John Patrick Moylan 2026-05-04Form 42026-05-050000711377-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
128Section 02, Amy Rocklin 2026-05-18Form 42026-05-190000711377-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
129Section 02, Amy Rocklin 2026-05-18Form 42026-05-190000711377-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
130Section 02, Amy Rocklin 2026-05-18Form 42026-05-190000711377-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
131Section 02, John Patrick Moylan 2026-06-03Form 42026-06-040000711377-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
132Section 06, 2025 voteForm 8-K2025-10-270001193125-25-250823Item 5.07 · say-on-pay result. As reported: 90.43% (votes for as printed: 167,126,873). Filing ↗
133Section 06, 2024 voteForm 8-K2024-10-280000950170-24-117710Item 5.07 · say-on-pay result. As reported: 48.76% (votes for as printed: 96,518,858). Filing ↗
134Section 06, 2023 voteForm 8-K2023-10-310000950170-23-056922Item 5.07 · say-on-pay result. As reported: 96.72% (votes for as printed: 188,942,194). Filing ↗
135Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
136Section 09b board cost (computed)ComputedcomputedCash 721,667 + equity 741,150 + all other 0 = 1,462,817, summed across the director compensation table rows.machine: formula: Σ = 1,462,817
137Exact Sciences Corporation, Section 10b CEO totalDEF 14A2025-04-290001124140-25-000034CEO total compensation as printed in Exact Sciences Corporation's own proxy. As printed: 15,539,378. Filing ↗machine: span 1077855–1077865
138Charles River Laboratories, Inc., Section 10b CEO totalDEF 14A2026-03-310001104659-26-037367CEO total compensation as printed in Charles River Laboratories, Inc.'s own proxy. As printed: 15,435,220. Filing ↗machine: r1 · c53 · span 1119658–1119668
139Natera, Inc., Section 10b CEO totalDEF 14A2026-04-230001104659-26-047770CEO total compensation as printed in Natera, Inc.'s own proxy. As printed: 14,957,319. Filing ↗machine: t190 · r5 · c14 · span 1269868–1269878
140IDEXX Laboratories, Inc., Section 10b CEO totalDEF 14A2026-03-270000874716-26-000064CEO total compensation as printed in IDEXX Laboratories, Inc.'s own proxy. As printed: 14,580,122. Filing ↗machine: span 1576008–1576018
141Waters Corporation, Section 10b CEO totalDEF 14A2026-04-090001193125-26-149657CEO total compensation as printed in Waters Corporation's own proxy. As printed: 13,973,044. Filing ↗machine: r5 · c18 · span 568522–568533
142QuidelOrtho Corporation, Section 10b CEO totalDEF 14A2026-04-270001906324-26-000018CEO total compensation as printed in QuidelOrtho Corporation's own proxy. As printed: 11,255,782. Filing ↗machine: r4 · c24 · span 760612–760622
143Sotera Health Company, Section 10b CEO totalDEF 14A2026-04-080001104659-26-040937CEO total compensation as printed in Sotera Health Company's own proxy. As printed: 10,656,063. Filing ↗machine: span 996859–996869
144Azenta, Inc., Section 10b CEO totalDEF 14A2025-12-180001140361-25-046064CEO total compensation as printed in Azenta, Inc.'s own proxy. As printed: 10,371,414. Filing ↗machine: r2 · c22 · span 1247118–1247129
145Maravai LifeScience Holdings, Inc., Section 10b CEO totalDEF 14A2026-04-240001823239-26-000014CEO total compensation as printed in Maravai LifeScience Holdings, Inc.'s own proxy. As printed: 10,129,708. Filing ↗machine: t21 · r3 · c20 · span 502645–502655
146NeoGenomics, Inc., Section 10b CEO totalDEF 14A2026-04-060001077183-26-000014CEO total compensation as printed in NeoGenomics, Inc.'s own proxy. As printed: 9,127,092. Filing ↗machine: r2 · c45 · span 869460–869469
147Guardant Health, Inc., Section 10b CEO totalDEF 14A2026-04-280001193125-26-187403CEO total compensation as printed in Guardant Health, Inc.'s own proxy. As printed: 8,661,227. Filing ↗machine: r7 · c31 · span 773149–773158
148Bio-Techne Corporation, Section 10b CEO totalDEF 14A2025-09-190001308179-25-000599CEO total compensation as printed in Bio-Techne Corporation's own proxy. As printed: 8,151,181. Filing ↗machine: span 792074–792083
149Bio-Rad Laboratories, Inc., Section 10b CEO totalDEF 14A2026-03-250000012208-26-000020CEO total compensation as printed in Bio-Rad Laboratories, Inc.'s own proxy. As printed: 7,995,841. Filing ↗machine: r2 · c24 · span 654200–654209
150Neogen (subject), Section 10b CEO totalDEF 14A2025-09-120000950170-25-114381CEO total compensation as printed in Neogen's own proxy. As printed: 6,824,891. Filing ↗machine: r3 · c31 · span 1277142–1277151
151Mettler-Toledo International, Inc., Section 10b CEO totalDEF 14A2026-03-180001174947-26-000389CEO total compensation as printed in Mettler-Toledo International, Inc.'s own proxy. As printed: 6,741,212. Filing ↗machine: r2 · c7 · span 643529–643538
152Repligen Corporation, Section 10b CEO totalDEF 14A2026-04-020001193125-26-140115CEO total compensation as printed in Repligen Corporation's own proxy. As printed: 6,114,771. Filing ↗machine: t16 · r4 · c2 · span 577065–577074
153Bruker Corporation, Section 10b CEO totalDEF 14A2026-04-100001193125-26-151305CEO total compensation as printed in Bruker Corporation's own proxy. As printed: 4,706,388. Filing ↗machine: t77 · r2 · c18 · span 987303–987312
154OraSure Technologies, Inc., Section 10b CEO totalDEF 14A2026-04-300001116463-26-000032CEO total compensation as printed in OraSure Technologies, Inc.'s own proxy. As printed: 4,292,228. Filing ↗machine: t152 · r2 · c21 · span 850376–850385
155Section 10a, Sotera Health Company reciprocityDEF 14A0001104659-26-040937Sotera Health Company's most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
156Section 10a, Maravai LifeScience Holdings, Inc. reciprocityDEF 14A0001823239-26-000014Maravai LifeScience Holdings, Inc. names Neogen in its own disclosed peer group (read from its most recent proxy). Filing ↗
157Section 10a, NeoGenomics, Inc. reciprocityDEF 14A0001077183-26-000014NeoGenomics, Inc.'s most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
158Section 10a, Azenta, Inc. reciprocityDEF 14A0001140361-25-046064Azenta, Inc.'s most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
159Section 10a, Waters Corporation reciprocityDEF 14A0001193125-26-149657Waters Corporation's most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
160Section 10a, IDEXX Laboratories, Inc. reciprocityDEF 14A0000874716-26-000064IDEXX Laboratories, Inc.'s most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
161Section 10a, OraSure Technologies, Inc. reciprocityDEF 14A0001116463-26-000032OraSure Technologies, Inc.'s most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
162Section 10a, Natera, Inc. reciprocityDEF 14A0001104659-26-047770Natera, Inc.'s most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
163Section 10a, Charles River Laboratories, Inc. reciprocityDEF 14A0001104659-26-037367Charles River Laboratories, Inc.'s most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
164Section 10a, Repligen Corporation reciprocityDEF 14A0001193125-26-140115Repligen Corporation names Neogen in its own disclosed peer group (read from its most recent proxy). Filing ↗
165Section 10a, Mettler-Toledo International, Inc. reciprocityDEF 14A0001174947-26-000389Mettler-Toledo International, Inc.'s most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
166Section 10a, Guardant Health, Inc. reciprocityDEF 14A0001193125-26-187403Guardant Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
167Section 10a, Exact Sciences Corporation reciprocityDEF 14A0001124140-25-000034Exact Sciences Corporation's most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
168Section 10a, QuidelOrtho Corporation reciprocityDEF 14A0001906324-26-000018QuidelOrtho Corporation's most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
169Section 10a, Bio-Techne Corporation reciprocityDEF 14A0001308179-25-000599Bio-Techne Corporation's most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗
170Section 10a, Bruker Corporation reciprocityDEF 14A0001193125-26-151305Bruker Corporation's most recent proxy was read; its disclosed peer group does not include Neogen. Filing ↗